The genetics of alcohol-related liver disease
Alcohol and Alcohol-related Diseases, Page: 975-996
2023
- 9Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures9
- Readers9
Book Chapter Description
Significant advances into the genetics of alcohol-related liver disease (ALD) have been made in the last two decades. Most notably, this includes the discovery of ten common genetic variants associated either with alcohol-related cirrhosis and/or hepatocellular carcinoma. These novel associations provide insight into the pathophysiology of ALD and have led directly to potentially new therapeutic targets, which are the subject of ongoing research. In addition, several genetic risk scores are now available to identify patients at high/low risk of developing cirrhosis, albeit their performance may not yet be adequate to enable risk stratification in the clinic. Prospectively, the increasing accessibility of population-level biobank data together with the emergence of whole genome sequencing data will likely lead to further discoveries in the years ahead. In this chapter, we will review the key genetic association studies performed so far in relation to ALD, discuss the potential clinical applications, and identify areas worthy of future research.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85198588417&origin=inward; http://dx.doi.org/10.1007/978-3-031-32483-3_52; https://link.springer.com/10.1007/978-3-031-32483-3_52; https://dx.doi.org/10.1007/978-3-031-32483-3_52; https://link.springer.com/chapter/10.1007/978-3-031-32483-3_52
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know